Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 18Mai
We now offer affordable ultra-sensitive biomarker detection with Simoa™ technology
Read More → - 04Mai
The changing environment in pyrogen and endotoxin testing
Read More → - 04Mai
Meet us at the Lonza Endotoxin Summit Annapolis, USA
Read More → - 04Mai
Meet us at the PharmaLab 2018 Düsseldorf/Neuss, Germany
Read More → - 27Feb
Low Endotoxin Recovery/Masking Training Munich/Bernried, Germany
Read More → - 12Jan
pLDH recombinant panels for malaria diagnostic tests
Read More → - 04Sep
Press release: HRP2 recombinant panel now available for malaria rapid diagnostic tests
Read More → - 22Jun
Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Read More → - 14Jun
Microcoat announces the launch of WATSON bioanalytical LIMS
Read More → - 31Jan
Press release: Positive control wells now available for rapid on-site quality assurance of Malaria rapid tests
Read More →
